📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Bayesian model-free approach to combination therapy phase I trials using censored time-to-toxicity data. (2019)

First Author: Wheeler GM

Attributed to: Adaptive Clinical Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/rssc.12323

PubMed Identifier: 30880843

Publication URI: http://europepmc.org/abstract/MED/30880843

Type: Journal Article/Review

Volume: 68

Parent Publication: Journal of the Royal Statistical Society. Series C, Applied statistics

Issue: 2

ISSN: 0035-9254